• $5.2M
    Market Cap
  • -80.69%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
63,573
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
9.7M
+23.13%
Gross Profit
0
N/A
0
N/A
0
+100.00%
-9.6M
+22.33%
Sales and Marketing Expense
4.8M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.9M
-64.28%
-8.2M
+101.58%
-4.1M
-27.98%
-5.7M
+63.36%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
7.8M
-37.88%
12.5M
+55.60%
8.0M
-41.29%
13.7M
+11.78%
Operating Profit
-7.8M
-37.88%
-12.5M
+55.60%
-8.0M
-16.88%
-9.7M
+23.13%
Interest Income
215,041
-4.76%
225,781
-8.67%
247,216
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
215,041
-4.76%
225,781
-8.67%
247,216
N/A
0
+100.00%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
63,573
+39.37%
Income before Taxes
-7.8M
-37.88%
-12.5M
+55.60%
-8.0M
-16.33%
-9.6M
-8.16%
Income Taxes
N/A
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-12.3M
+57.64%
-7.8M
-18.90%
-9.6M
+21.62%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-12.3M
+57.64%
-7.8M
-18.90%
-9.6M
-8.16%
Basic EPS and Net Income
-8.16
+1.62%
-8.03
+200.75%
-2.67
+206.90%
-0.87
-64.20%
Diluted EPS and Net Income
-8.16
+1.62%
-8.03
+200.75%
-2.67
+206.90%
-0.87
-64.20%
Basic Weighted Average Shares
926,192
-39.46%
1.5M
N/A
N/A
N/A
11.1M
+156.86%
Diluted Weighted Average Shares
926,192
-39.46%
1.5M
N/A
N/A
N/A
11.1M
+156.86%
Balance Sheet
Cash and Cash Equivalents
7.5M
+137.92%
3.2M
-57.50%
7.4M
+19.18%
6.2M
-42.20%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.5M
+137.92%
3.2M
-57.50%
7.4M
+19.18%
6.2M
-42.20%
Total Current Assets
7.9M
+122.53%
3.5M
-55.71%
8.0M
+14.89%
6.9M
-40.26%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
2.6M
N/A
Total Assets
7.9M
+122.53%
3.5M
-55.71%
8.0M
+14.89%
6.9M
-40.26%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
1.3M
N/A
Total Current Liabilities
460,811
-42.97%
808,011
-6.70%
866,028
-6.14%
922,634
-39.17%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
1.5M
N/A
Total Long-Term Liabilities
N/A
N/A
0
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.6M
-16.85%
2.0M
+21.51%
1.6M
+75.98%
922,634
-39.17%
Retained Earnings
-73.2M
+11.51%
-65.7M
+23.02%
-53.4M
+17.10%
-45.6M
+26.71%
Total Stockholders Equity
6.2M
+298.66%
1.6M
-75.44%
6.4M
+5.53%
6.0M
-40.42%
Total Shares Outstanding
537,750
-78.64%
2.5M
-35.95%
3.9M
-68.10%
12.3M
+47.95%
Cash Flow
Cash from Operating Activities
-7.8M
-30.51%
-11.2M
+74.18%
-6.4M
-27.45%
-8.8M
+55.17%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cash from Financing Activities
12.1M
+75.97%
6.9M
-9.46%
7.6M
+77.84%
4.3M
-73.21%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
-15,117.92%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-15,217.92%
N/A
Return on Assets
N/A
N/A
-213.46%
+104.34%
-104.46%
+0.91%
-103.52%
N/A
Return on Equity
N/A
N/A
-310.44%
+146.47%
-125.96%
+5.69%
-119.18%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
17.07
+290.19%
4.37
-52.53%
9.21
+22.40%
7.53
N/A
Cash Ratio
16.32
+317.18%
3.91
-54.44%
8.59
+26.97%
6.76
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.45
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.39
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow